Skip to main content
. 2012 Nov 19;121(6):884–892. doi: 10.1182/blood-2012-05-432203

Table 2.

Cytogenetic risk-stratification of myeloma

Standard-risk Intermediate-risk High-risk
Trisomies* t(4;14) 17p deletion
t(11;14) t(14;16)
t(6;14) t(14;20)

Modified from Rajkumar et al5 with permission.

*

Presence of trisomies abrogates the poor prognostic impact of high-risk disease.